Stock Screener App

Gratuito -

Installare

39.71

1.38% 0.54

Mineralys Therapeutics Inc (MLYS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Mineralys Therapeutics Inc Azioni (MLYS) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	5.17% 46.75	44.45	60.11	45.17	35.36
Operating Income/Loss	5.17% -46.75	-44.45	-60.11	-45.17	-35.36
Nonoperating Income/Loss	55.28% 3.472	2.236	3.764	4.154	3.854
Income/Loss From Continuing Operations Before Tax	2.52% -43.27	-42.21	-56.34	-41.01	-31.51
Income/Loss From Continuing Operations After Tax	2.52% -43.27	-42.21	-56.34	-41.01	-31.51
Net Income/Loss	2.52% -43.27	-42.21	-56.34	-41.01	-31.51
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	23.11% 65.45	53.16	49.82	49.36	44.90
Diluted Average Shares	23.11% 65.45	53.16	49.82	49.36	44.90
Basic Earnings Per Share	16.46% -0.66	-0.79	-1.13	-0.83	-0.70
Diluted Earnings Per Share	16.46% -0.66	-0.79	-1.13	-0.83	-0.70
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.76

1.09%

GMAB

$28.91

0.72%

INCY

$102.30

0.64%

BNTX

$104.01

0.05%

ONC

$310.20

0.46%

INSM

$183.65

1.35%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters